These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6343491)

  • 41. Immunologic studies of a case of myasthenia gravis associated with pemphigus vulgaris after thymomectomy.
    Noguchi S; Nishitani H
    Neurology; 1976 Nov; 26(11):1075-80. PubMed ID: 988515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skeletal and heart muscle antibodies in myasthenia gravis. A new immunofluorescence pattern.
    Cossio PM; Cornejo L; Herrera M; Vasquez C; Arana RM
    Biomedicine; 1973 Jun; 19(6):261-6. PubMed ID: 4584701
    [No Abstract]   [Full Text] [Related]  

  • 43. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunopathology of myasthenia gravis. Comparison of myasthenic sceletal muscle antibodies with rabbit and rat antibodies produced by immunization with skeletal muscle proteins].
    Stroehmann I; Ricken D; Naubereit M; Bruchhausen D
    Res Exp Med (Berl); 1973 May; 160(3):181-95. PubMed ID: 4122532
    [No Abstract]   [Full Text] [Related]  

  • 45. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens.
    Gilhus NE; Aarli JA; Matre R
    J Neuroimmunol; 1983 Dec; 5(3):239-49. PubMed ID: 6361067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Autoimmunity in myasthenia and thymoma].
    Feltkamp TE
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):468-72. PubMed ID: 4912021
    [No Abstract]   [Full Text] [Related]  

  • 48. Myasthenia gravis-associated antibodies in asymptomatic thymoma.
    Moore HJ; Woods EL
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):308-10. PubMed ID: 3968916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
    Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
    Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.
    Strauss AJ; Smith CW; Cage GW; van der Geld HW; McFarlin DE; Barlow M
    Ann N Y Acad Sci; 1966 Jan; 135(1):557-79. PubMed ID: 4161396
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunopathology of myasthenia].
    Eyquem A; Duc HT
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):115-6. PubMed ID: 4565629
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.
    Dawkins RL
    Clin Exp Immunol; 1975 Aug; 21(2):185-201. PubMed ID: 52425
    [No Abstract]   [Full Text] [Related]  

  • 53. Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.
    Williams CL; Lennon VA
    J Exp Med; 1986 Oct; 164(4):1043-59. PubMed ID: 3020150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-titin antibodies are not associated with a specific thymoma histology.
    Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
    [No Abstract]   [Full Text] [Related]  

  • 55. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. REACTIVITY OF MYASTHENIA GRAVIS SERUM GAMMA-GLOBULIN WITH SKELETAL MUSCLE AND THYMUS DEMONSTRATED BY IMMUNOFLUORESCENCE.
    VAN DER GELD H; FELTKAMP TE; OOSTERHUIS HJ
    Proc Soc Exp Biol Med; 1964 Mar; 115():782-5. PubMed ID: 14155828
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunological concomitants of myasthenia gravis.
    Strauss AJ; van der Geld HW; Kemp PG; Exum ED; Goodman HC
    Ann N Y Acad Sci; 1965 Jun; 124(2):744-66. PubMed ID: 5320505
    [No Abstract]   [Full Text] [Related]  

  • 58. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
    Chen XJ; Qiao J; Xiao BG; Lu CZ
    J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative antistriate muscle antibody titers in malignant thymoma associated with myasthenia gravis: case report.
    Watters MR
    Mil Med; 1983 Feb; 148(2):145-7. PubMed ID: 6405314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.